IP Library Granted Patent US 8,075,926
Granted Patent B2
US 8,075,926 · App. 12/417,106 · Granted Dec 13, 2011

Herbal compositions for the treatment of mucosal lesions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,075,926
App. No.
12/417,106
Granted
Dec 13, 2011
Kind
B2
Abstract

The present invention provides therapeutic compositions comprising extracts of the plant species Echinacea purpurea and Sambucus nigra and the extract(s) of at least one further plant selected from the group consisting of Hypericum perforatum, Commiphora molmol and Centella asiatica . The compositions of the invention are of particular utility in the management of inflammatory mucosal diseases of both viral and non-viral origin.

Claims (13)

1. A method of treatment of mucosal lesions comprising the application of a therapeutically-effective amount of a mixture of extracts of the plant species Echinacea purpurea Sambucus nigra and Centella asiatica to the mucosal lesions and surrounding tissue of a subject in need of such treatment.

2. A method of treatment according to claim 1 , wherein the mucosal lesions are oral lesions associated with a disease selected from the group consisting of periodontal disease, gingivitis, aphthous ulceration, mechanical trauma, thermal trauma, lichen planus, bullous pemphigoid, pemphigus vulgaris, dermatitis herpetiformis, angular chelitis and recurrent herpes.

3. A method of treatment according to claim 1 , wherein the mucosal lesions are anal lesions associated with a disease selected from the group consisting of anal fissures, hemorrhoids and non-specific irritation.

4. A method of inhibiting one or more matrix metalloproteinases in mucosal and/or skin lesions of a subject in need of such treatment, comprising the application of a therapeutically-effective amount of a mixture of extracts of the plant species Echinacea purpurea, Sambucus nigra and Centella asiatica to said mucosal and/or skin lesions and surrounding tissue.

5. A method according to claim 4 , wherein the one or more matrix metalloproteinases are selected from the group consisting of matrix metalloproteinases 1 to 9.

6. A method according to claim 5 , wherein the one or more matrix metalloproteinases are selected from the group consisting of matrix metalloproteinases 1, 2, 8 and 9.

7. A method according to any one of claims 4 , 5 and 6 , wherein the inhibition of the one or more matrix metalloproteinases is used in the treatment of periodontal disease.

8. A method according to any one of claims 4 , 5 and 6 , wherein the inhibition of the one or more matrix metalloproteinases is used in the treatment of aphthous ulceration.

9. A method according to any one of claims 2 to 6 , wherein the mixture of plant extracts further comprises extracts of plants selected from the group consisting of Gotu kola, Uncaria tomentosa, Thymus vulgaris, Matricaria recutita, Salix alba, Calendula officinalis, Usnea barbata, Ligusticum porterii - osha, Gaultheria procumbens, Camellia sinensis, Vaccinium myrtillus, Melissa officinalis, Allium sativum, Camellia sinensis and Krameria triandra.

10. A method for inhibiting one or more matrix metalloproteinases in vitro, comprising contacting an effective amount of a mixture of extracts of the plant species Echinacea purpurea, Sambucus nigra and Centella asiatica with said one or more matrix metalloproteinases.

11. A method according to claim 10 , wherein the one or more matrix metalloproteinases to be inhibited are selected from the group consisting of matrix metalloproteinases 1 to 9.

12. A method according to claim 11 , wherein the one or more matrix metalloproteinases to be inhibited are selected from the group consisting of matrix metalloproteinases 1, 2, 8 and 9.

13. A method of treatment of skin lesions comprising the application of a therapeutically-effective amount of a mixture of extracts of the plant species Echinacea purpurea, Sambucus nigra and Centella asiatica to the skin lesions and surrounding tissue of a subject in need of such treatment.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded May 19, 2025
From: IZUN PHARMACEUTICALS CORPORATION
To: KALMAN, JONATHAN, MR.
Reel/Frame 071152/0608 →
SECURITY INTEREST Recorded Jun 30, 2021
From: IZUN PHARMACEUTICALS CORPORATION
To: JONATHAN KALMAN
Reel/Frame 056716/0583 →
RELEASE OF SECURITY INTEREST Recorded Jan 8, 2019
From: IZUN PHARMACEUTICALS CORPORATION
To: HAHN, ELLIOT F
Reel/Frame 047934/0363 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBERS 14193345 AND 15006421 PREVIOUSLY RECORDED AT REEL: 040824 FRAME: 0202. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Dec 28, 2017
From: IZUN PHARMACEUTICALS CORPORATION
To: HAHN, ELLIOT F
Reel/Frame 045032/0099 →
SECURITY AGREEMENT Recorded Dec 6, 2016
From: IZUN PHARMACEUTICALS CORPORATION
To: HAHN, ELLIOT F
Reel/Frame 040824/0202 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2009
From: LEVINE, WILLIAM Z.; SAFFER, ARON J.; FARAN, MINA
To: HERBAL SYNTHESIS CORPORATION
Reel/Frame 022505/0490 →
CHANGE OF NAME Recorded Apr 2, 2009
From: HERBAL SYNTHESIS CORPORATION
To: IZUN PHARMACEUTICALS CORPORATION
Reel/Frame 022513/0198 →